214 related articles for article (PubMed ID: 32707596)
1. Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer.
Cheng H; He W; Yang J; Ye Q; Cheng L; Pan Y; Mao L; Chu X; Lu C; Li G; Qiu Y; He J
Cell Prolif; 2020 Sep; 53(9):e12880. PubMed ID: 32707596
[TBL] [Abstract][Full Text] [Related]
2. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
3. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
[TBL] [Abstract][Full Text] [Related]
4. Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness.
Zhou Q; Geng Q; Wang L; Huang J; Liao M; Li Y; Ding Z; Yang S; Zhao H; Shen Q; Pan C; Lou J; Lu S; Chen C; Luo Q
EBioMedicine; 2019 Mar; 41():236-243. PubMed ID: 30872130
[TBL] [Abstract][Full Text] [Related]
5. Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer.
Cheng H; Yang J; Fu X; Mao L; Chu X; Lu C; Li G; Qiu Y; He W
Front Oncol; 2022; 12():1012609. PubMed ID: 36313690
[TBL] [Abstract][Full Text] [Related]
6. Detection of folate receptor-positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer.
Wu Q; Zheng H; Gu J; Cheng Y; Qiao B; Wang J; Xiong L; Sun S; Wu Z; Bao A; Tong Y
J Clin Lab Anal; 2022 Jan; 36(1):e24180. PubMed ID: 34919735
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study].
Lian H; Ding Z; Yuan D; Ma J; Qin J
Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):813-820. PubMed ID: 27978866
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer.
Wang L; Wu C; Qiao L; Yu W; Guo Q; Zhao M; Yang G; Zhao H; Lou J
J Cancer; 2017; 8(1):104-110. PubMed ID: 28123603
[No Abstract] [Full Text] [Related]
9. High-throughput enrichment of portal venous circulating tumor cells for highly sensitive diagnosis of CA19-9-negative pancreatic cancer patients using inertial microfluidics.
Zhu Z; Zhang Y; Zhang W; Tang D; Zhang S; Wang L; Zou X; Ni Z; Zhang S; Lv Y; Xiang N
Biosens Bioelectron; 2024 Sep; 259():116411. PubMed ID: 38781696
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic Ultrasound-Guided Acquisition of Portal Venous Circulating Tumor Cells as a Potential Diagnostic and Prognostic Tool for Pancreatic Cancer.
Zhang Y; Su H; Wang H; Xu C; Zhou S; Zhao J; Shen S; Xu G; Wang L; Zou X; Zhang S; Lv Y
Cancer Manag Res; 2021; 13():7649-7661. PubMed ID: 34675662
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
[TBL] [Abstract][Full Text] [Related]
12. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
[TBL] [Abstract][Full Text] [Related]
13. A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases.
Tien YW; Kuo HC; Ho BI; Chang MC; Chang YT; Cheng MF; Chen HL; Liang TY; Wang CF; Huang CY; Shew JY; Chang YC; Lee EY; Lee WH
Medicine (Baltimore); 2016 Apr; 95(16):e3407. PubMed ID: 27100430
[TBL] [Abstract][Full Text] [Related]
14. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
Xu Y; Li Q; Lin Z; Lin Y
Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
[TBL] [Abstract][Full Text] [Related]
15. The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer.
Lv X; Wu S; Xu X; Wu L; Chang N; Zhang J; Ti X
J Thorac Dis; 2022 Jan; 14(1):158-168. PubMed ID: 35242377
[TBL] [Abstract][Full Text] [Related]
16. Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer.
Wei T; Zhang X; Zhang Q; Yang J; Chen Q; Wang J; Li X; Chen J; Ma T; Li G; Gao S; Lou J; Que R; Wang Y; Dang X; Zheng L; Liang T; Bai X
Cancer Lett; 2019 Jun; 452():237-243. PubMed ID: 30905814
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study.
Zhou Q; He Q; He W; Wang C; Liu G; Wang K; Li H; Li J; Xiao W; Fang Q; Peng L; Han Y; Wang D; Leng X
BMC Cancer; 2023 Nov; 23(1):1171. PubMed ID: 38037003
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications.
Pang TCY; Po JW; Becker TM; Goldstein D; Pirola RC; Wilson JS; Apte MV
Pancreatology; 2021 Jan; 21(1):103-114. PubMed ID: 33309014
[TBL] [Abstract][Full Text] [Related]
19. Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR.
Lou J; Ben S; Yang G; Liang X; Wang X; Ni S; Han B
PLoS One; 2013; 8(12):e80458. PubMed ID: 24324600
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]